rs371972266

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_001127222.2(CACNA1A):​c.5868C>T​(p.Tyr1956Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000329 in 1,612,706 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000092 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000027 ( 0 hom. )

Consequence

CACNA1A
NM_001127222.2 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: -0.821

Publications

4 publications found
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
  • episodic ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • developmental and epileptic encephalopathy, 42
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • migraine, familial hemiplegic, 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • spinocerebellar ataxia type 6
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • benign paroxysmal torticollis of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 19-13214305-G-A is Benign according to our data. Variant chr19-13214305-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 515383.
BP7
Synonymous conserved (PhyloP=-0.821 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.0000919 (14/152324) while in subpopulation EAS AF = 0.00232 (12/5180). AF 95% confidence interval is 0.00134. There are 0 homozygotes in GnomAd4. There are 8 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 14 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ANM_001127222.2 linkc.5868C>T p.Tyr1956Tyr synonymous_variant Exon 40 of 47 ENST00000360228.11 NP_001120694.1
CACNA1ANM_001127221.2 linkc.5871C>T p.Tyr1957Tyr synonymous_variant Exon 40 of 47 ENST00000638009.2 NP_001120693.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1AENST00000360228.11 linkc.5868C>T p.Tyr1956Tyr synonymous_variant Exon 40 of 47 1 NM_001127222.2 ENSP00000353362.5
CACNA1AENST00000638009.2 linkc.5871C>T p.Tyr1957Tyr synonymous_variant Exon 40 of 47 1 NM_001127221.2 ENSP00000489913.1
CACNA1AENST00000638029.1 linkc.5886C>T p.Tyr1962Tyr synonymous_variant Exon 41 of 48 5 ENSP00000489829.1
CACNA1AENST00000573710.7 linkc.5874C>T p.Tyr1958Tyr synonymous_variant Exon 40 of 47 5 ENSP00000460092.3
CACNA1AENST00000635727.1 linkc.5871C>T p.Tyr1957Tyr synonymous_variant Exon 40 of 47 5 ENSP00000490001.1
CACNA1AENST00000637769.1 linkc.5871C>T p.Tyr1957Tyr synonymous_variant Exon 40 of 47 1 ENSP00000489778.1
CACNA1AENST00000636012.1 linkc.5871C>T p.Tyr1957Tyr synonymous_variant Exon 40 of 46 5 ENSP00000490223.1
CACNA1AENST00000637736.1 linkc.5730C>T p.Tyr1910Tyr synonymous_variant Exon 39 of 46 5 ENSP00000489861.1
CACNA1AENST00000636389.1 linkc.5871C>T p.Tyr1957Tyr synonymous_variant Exon 40 of 47 5 ENSP00000489992.1
CACNA1AENST00000637432.1 linkc.5886C>T p.Tyr1962Tyr synonymous_variant Exon 41 of 48 5 ENSP00000490617.1
CACNA1AENST00000636549.1 linkc.5877C>T p.Tyr1959Tyr synonymous_variant Exon 41 of 48 5 ENSP00000490578.1
CACNA1AENST00000637927.1 linkc.5874C>T p.Tyr1958Tyr synonymous_variant Exon 40 of 47 5 ENSP00000489715.1
CACNA1AENST00000635895.1 linkc.5871C>T p.Tyr1957Tyr synonymous_variant Exon 40 of 47 5 ENSP00000490323.1
CACNA1AENST00000637276.1 linkc.5871C>T p.Tyr1957Tyr synonymous_variant Exon 40 of 46 5 ENSP00000489777.1
CACNA1AENST00000636768.2 linkn.*170C>T non_coding_transcript_exon_variant Exon 39 of 45 5 ENSP00000490190.2
CACNA1AENST00000713789.1 linkn.*1083C>T non_coding_transcript_exon_variant Exon 41 of 47 ENSP00000519091.1
CACNA1AENST00000636768.2 linkn.*170C>T 3_prime_UTR_variant Exon 39 of 45 5 ENSP00000490190.2
CACNA1AENST00000713789.1 linkn.*1083C>T 3_prime_UTR_variant Exon 41 of 47 ENSP00000519091.1

Frequencies

GnomAD3 genomes
AF:
0.0000854
AC:
13
AN:
152206
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00212
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000121
AC:
30
AN:
248046
AF XY:
0.0000965
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000870
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00134
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000887
Gnomad OTH exome
AF:
0.000166
GnomAD4 exome
AF:
0.0000267
AC:
39
AN:
1460382
Hom.:
0
Cov.:
31
AF XY:
0.0000248
AC XY:
18
AN XY:
726544
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.0000671
AC:
3
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.000730
AC:
29
AN:
39700
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86252
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52150
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1111834
Other (OTH)
AF:
0.0000497
AC:
3
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.449
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000919
AC:
14
AN:
152324
Hom.:
0
Cov.:
32
AF XY:
0.000107
AC XY:
8
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41574
American (AMR)
AF:
0.0000654
AC:
1
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00232
AC:
12
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68040
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.537
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.0000604
Asia WGS
AF:
0.00318
AC:
11
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Feb 24, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 14, 2017
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Oct 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jun 12, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.50
CADD
Benign
4.4
DANN
Benign
0.44
PhyloP100
-0.82

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs371972266; hg19: chr19-13325119; COSMIC: COSV64199640; COSMIC: COSV64199640; API